UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents

Journal of the American College of Cardiology, 2011-06, Vol.58 (1), p.19-25

2011

Volltextzugriff (PDF)

Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease

JACC. Cardiovascular interventions, 2013-09, Vol.6 (9), p.914-922

2013

Volltextzugriff (PDF)

Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation

JACC. Cardiovascular interventions, 2012-06, Vol.5 (6), p.626-635

2012

Volltextzugriff (PDF)

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

EuroIntervention, 2015-04, Vol.10 (12), p.1396-1401

2015

Volltextzugriff (PDF)

Three‐year clinical outcomes of patients treated with everolimus‐eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial

Catheterization and cardiovascular interventions, 2019-01, Vol.93 (1), p.E1-E7

2019

Volltextzugriff (PDF)

Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction

Vascular health and risk management, 2006, Vol.2 (2), p.153-156

Sudhir, Krishnankutty

2006

Volltextzugriff (PDF)

Long-Term (Three-Year) Safety and Efficacy of Everolimus -Eluting Stents Compared to Paclitaxel -Eluting Stents (from the SPIRIT III Trial)

The American journal of cardiology, 2011-03, Vol.107 (6), p.833-840

2011

Volltextzugriff (PDF)

Transient Left Ventricular Dysfunction Under Severe Stress: Brain-Heart Relationship Revisited

The American journal of medicine, 2006, Vol.119 (1), p.10-17

2006

Volltextzugriff (PDF)

Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials

Journal of cardiology, 2021-09, Vol.78 (3), p.224-229

2021

Volltextzugriff (PDF)

SPIRIT III JAPAN Versus SPIRIT III USA: A Comparative Intravascular Ultrasound Analysis of the Everolimus-Eluting Stent

The American journal of cardiology, 2010-07, Vol.106 (1), p.13-17

2010

Volltextzugriff (PDF)

Variations in Endothelial Function and Arterial Compliance during the Menstrual Cycle

The journal of clinical endocrinology and metabolism, 2001-11, Vol.86 (11), p.5389-5395

2001

Volltextzugriff (PDF)

Cellular mechanisms underlying the cardiovascular actions of oestrogens

Clinical science (1979), 2006-08, Vol.111 (2), p.107-118

2006

Volltextzugriff (PDF)

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials

EuroIntervention, 2012-09, Vol.8 (5), p.599-606

2012

Volltextzugriff (PDF)

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

EuroIntervention, 2010-04, Vol.5 (8), p.932-938

2010

Volltextzugriff (PDF)

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent

Coronary artery disease, 2010-01, Vol.21 (1), p.46-56

2010

Volltextzugriff (PDF)

Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial

International journal of cardiology. Heart & vasculature, 2020-12, Vol.31, p.100623-100623, Article 100623

2020

Volltextzugriff (PDF)

CLINICAL REVIEW: Lipoprotein-Associated Phospholipase A2, a Novel Inflammatory Biomarker and Independent Risk Predictor for Cardiovascular Disease

The journal of clinical endocrinology and metabolism, 2005-05, Vol.90 (5), p.3100-3105

Sudhir, Krishnankutty

2005

Volltextzugriff (PDF)

Endogenous Estrogens Influence Endothelial Function in Young Men

Circulation research, 2003-11, Vol.93 (11), p.1127-1133

2003

Volltextzugriff (PDF)

Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: A report from the SPIRIT V single arm study

Catheterization and cardiovascular interventions, 2013-09, Vol.82 (3), p.E163-E172

2013

Volltextzugriff (PDF)

Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years

The American journal of cardiology, 2012-07, Vol.110 (1), p.21-29

2012

Volltextzugriff (PDF)

SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease

The American heart journal, 2009-10, Vol.158 (4), p.520-526.e2

2009

Volltextzugriff (PDF)

Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial

The American heart journal, 2009-12, Vol.158 (6), p.1005-1010

2009

Volltextzugriff (PDF)

5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents

JACC. Cardiovascular interventions, 2013-12, Vol.6 (12), p.1263-1266

2013

Volltextzugriff (PDF)

Three-Year Results of Safety and Efficacy of the Everolimus -Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)

The American journal of cardiology, 2011-03, Vol.107 (6), p.841-848

2011

Volltextzugriff (PDF)

Three-year data from the XIENCE V® INDIA study: Safety and efficacy of XIENCE V® in 1000 real world Indian patients

Indian heart journal, 2014-05, Vol.66 (3), p.302-308

2014

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(232)

Publikationsform

Artikel
(253)
Reviews
(3)
Berichte
(1)

Sprache

Englisch
(257)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(144)
Science & Technology
(144)
Humans
(125)
Cardiovascular System & Cardiology
(114)
Cardiac & Cardiovascular Systems
(100)
Male
(100)
Biological And Medical Sciences
(99)
Female
(96)
Medical Sciences
(87)
Middle Aged
(76)
Aged
(57)
Everolimus
(55)
Animals
(49)
Drug-Eluting Stents
(49)
Sirolimus - Analogs & Derivatives
(49)
Treatment Outcome
(46)
Cardiology. Vascular System
(42)
Sirolimus - Administration & Dosage
(42)
Cardiovascular
(38)
Time Factors
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents

Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

Three‐year clinical outcomes of patients treated with everolimus‐eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial

Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction

Long-Term (Three-Year) Safety and Efficacy of Everolimus -Eluting Stents Compared to Paclitaxel -Eluting Stents (from the SPIRIT III Trial)

Transient Left Ventricular Dysfunction Under Severe Stress: Brain-Heart Relationship Revisited

Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials

SPIRIT III JAPAN Versus SPIRIT III USA: A Comparative Intravascular Ultrasound Analysis of the Everolimus-Eluting Stent

Variations in Endothelial Function and Arterial Compliance during the Menstrual Cycle

Cellular mechanisms underlying the cardiovascular actions of oestrogens

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent

Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial

CLINICAL REVIEW: Lipoprotein-Associated Phospholipase A2, a Novel Inflammatory Biomarker and Independent Risk Predictor for Cardiovascular Disease

Endogenous Estrogens Influence Endothelial Function in Young Men

Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: A report from the SPIRIT V single arm study

Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years

SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease

Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial

5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents

Three-Year Results of Safety and Efficacy of the Everolimus -Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)

Three-year data from the XIENCE V® INDIA study: Safety and efficacy of XIENCE V® in 1000 real world Indian patients

Suchergebnisse filtern